Research ArticleFeatured Articles

Epidemiology, Costs, Consequences, and Pathophysiology of Type 2 Diabetes: An American Epidemic

Lawrence Blonde
Ochsner Journal July 2001, 3 (3) 126-131;

References

  1. ↵
    1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
    (1997) Diabetes Care 20:1183–1197, pmid:9203460.
    OpenUrlFREE Full Text
  2. ↵
    1. World Health Organization
    , Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Organization, 1985 (Tech. Rep. Ser., no. 727).
  3. ↵
    1. Mokdad A. H.,
    2. Ford E. S.,
    3. Bowman B. A.
    (2000) Diabetes trends in the US: 1990–1998. Diabetes Care 23:1278–1283, pmid:10977060.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Rosenbloom A. L.,
    2. Joe J. R.,
    3. Young R. S.,
    4. Winter W. E.
    (1999) Emerging epidemic of type 2 diabetes in youth. Diabetes Care 22:345–354, pmid:10333956.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Harris M.
    In: Diabetes in America/National Diabetes Data Group. 2nd ed, Chapt 1. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 1995.
  6. ↵
    1. American Diabetes Association
    , Diabetes Facts and Figures [serial online]. March 2000.
  7. ↵
    1. National Institute of Diabetes and Digestive and Kidney Diseases
    , Kidney Disease of Diabetes [serial online]. March 2000. http://www.niddk.nih.gov/health/kidney/pubs/kdd/kdd.htm.
  8. ↵
    1. Haffner S. M.,
    2. Lehto S.,
    3. Ronnemaa T.
    (1998) Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–234, pmid:9673301.
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    1. McKinlay J.,
    2. Marceau L.
    (2000) US public health and the 21st century: diabetes mellitus. Lancet 356:757–761, pmid:11085708.
    OpenUrlCrossRefPubMedWeb of Science
  10. ↵
    1. Economic consequences of diabetes mellitus in the U.S. in 1997
    (1998) American Diabetes Association. Diabetes Care 21:296–309, pmid:9539999.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Gilmer T. P.,
    2. O'Connor P. J.,
    3. Manning W. G.
    (1997) The cost to health plans of poor glycemic control. Diabetes Care 20:1847–1853, pmid:9405905.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. UK Prospective Diabetes Study (UKPDS) Group
    (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, pmid:9742976.
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    1. Stratton I. M.,
    2. Adler A. I.,
    3. Neil H. A.
    (2000) Association of glycaemia with macrovascular and microvascular complications type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412, pmid:10938048.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Malmberg K.
    (1997) Prospective randomised study on intensive insulin treatment of long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314:1512–1515, pmid:9169397.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Wagner E. H.,
    2. Sandhu N.,
    3. Newton K. M.
    (2001) Effect of improved glycemic control on health care costs and utilization. JAMA 285:182–189, pmid:11176811.
    OpenUrlCrossRefPubMedWeb of Science
  16. ↵
    1. Gray A.,
    2. Raikou M.,
    3. McGuire A.
    (2000) Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ 320:1373–1378, pmid:10818026.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Diabetes Surveillance Statistics, 1999
    , National Center for Chronic Disease Prevention and Health Promotion, Diabetes Public Health Resource. www.cdc.gov/diabetes/statistics/survl99/chap9/contents.htm. Accessed May 7, 2001.
  18. ↵
    1. Testa M. A.,
    2. Simonson D. C.
    (1998) Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled, double-blind trial. JAMA 280:1490–1496, pmid:9809729.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Weyer C.,
    2. Bogardus C.,
    3. Mott D. M.
    (1999) The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787–794, pmid:10491414.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Skyler J.
    Approach to hyperglycemia in the patient with diabetes mellitus; therapeutic objectives in type I diabetes. In: Humes HD, DuPont HL, et al (eds): Kelley's Textbook of Intern Medicine. Philadelphia: Lippincott Williams & Wilkins, 2000.
  21. ↵
    1. McCulloch D. K.
    Insulin secretion and pancreatic beta cell function. In UpToDate.
  22. ↵
    1. Robertson R. P.,
    2. Porte D. Jr.
    (1973) The glucose receptor. A defective mechanism in diabetes mellitus distinct from the beta adrenergic receptor. J Clin Invest 52:870–876, pmid:4693651.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Tominaga M.,
    2. Eguchi H.,
    3. Manaka H.
    (1999) Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care 22:920–924, pmid:10372242.
    OpenUrlAbstract
  24. ↵
    1. Herman W. H.,
    2. Engelgau M. M.,
    3. Zhang Y.
    (2000) Use of GHb (HbA(1c)) to screen for undiagnosed diabetes in the U.S. population. Diabetes Care 23:1207–1208, pmid:10937532.
    OpenUrlFREE Full Text
  25. ↵
    1. Standards of Medical Care for Patients With Diabetes Mellitus
    (2001) American Diabetes Association. Diabetes Care 24(1):33–43, pmid:11194237, Suppl, s, http://journal.diabetes.org/FullText/Supplements/DiabetesCare/Supplement101/S33.htm. Accessed May 7, 2001.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus
    (2000) The AACE System of Intensive Diabetes Self-Management-2000 Update. Endocrine Practice 6(1).
  27. ↵
    1. Avignon A.,
    2. Radauceanu A.,
    3. Monnier L.
    (1997) Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes. Diabetes Care 20:1822–1826, pmid:9405900.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Franz M. J.,
    2. Monk A.,
    3. Barry B.
    (1995) Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, control clinical trial. J Am Diet Assoc 95:1009–1017, pmid:7657902.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Diabetes Mellitus and Exercise
    (2001) American Diabetes Association. Diabetes Care 24(1):51–55, pmid:11194241, Suppl, s, http://journal.diabetes.org/FullText/Supplements/DiabetesCare/Supplement101/S51.htm. Accessed May 7, 2001.
    OpenUrlAbstract/FREE Full Text
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section